Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Disease: An Immunohistochemical Study

Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Disease: An Immunohistochemical Study

Interleukins are considered to be potential therapeutic targets that can alter the prognosis and disease progression of IBD. IL-21 has proven to be involved in effector Th1, Th2 and Th17 responses. Similarly, IL-33, a newly identified cytokine, has been shown to control the Th1 effector response and...

Full description

Bibliographic Details
Main Authors: Alexandros Toskas, Stefanos Milias, Georgios Delis, Soultana Meditskou, Antonia Sioga, Theodora Papamitsou
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Diagnostics
Subjects:
IL-21
IL-33
IBD
Crohn’s
UC
immunochemistry
Online Access:https://www.mdpi.com/2075-4418/13/13/2185

Internet

https://www.mdpi.com/2075-4418/13/13/2185

Similar Items